Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Gerstner

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Neurology|January 30, 2008
Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiationElizabeth R Gerstner, Kathryn A Carson, Stuart A Grossman, et al.
Current Opinion in Neurology|November 8, 2008
Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomasElizabeth R Gerstner, A Gregory Sorensen, Rakesh K Jain, et al.
Current Neurology and Neuroscience Reports|April 8, 2009
Anti-vascular endothelial growth factor therapy for malignant gliomaElizabeth R Gerstner, A Gregory Sorensen, Rakesh K Jain, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2023
Labeling T Cells to Track Immune Response to Immunotherapy in GlioblastomaJohn Y Rhee, Jack Y Ghannam, Bryan D Choi, et al.
Cancer Research|September 4, 2014
Advanced magnetic resonance imaging of the physical processes in human glioblastomaJayashree Kalpathy-Cramer, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Journal of Neuro-Oncology|February 26, 2014
Impact of MRI head placement on glioma response assessmentMartin Reuter, Elizabeth R Gerstner, Otto Rapalino, et al.
Current Treatment Options in Oncology|April 22, 2024
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?Alexander F Wang, Brian Hsueh, Bryan D Choi, et al.
Neuro-Oncology Advances|July 27, 2022
Magnetic resonance spectroscopic imaging for detecting metabolic changes in glioblastoma after anti-angiogenic therapy-a systematic literature reviewMohamed E El-Abtah, Pratik Talati, Jorg Dietrich, et al.
Journal of Neuro-Oncology|February 18, 2009
Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progressionElizabeth R Gerstner, Margaret B McNamara, Andrew D Norden, et al.
Neuro-Oncology Practice|October 13, 2025
A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomasMaya Viera, Christopher W Mount, Dora Dias-Santagata, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Neurology|January 30, 2008
Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiationElizabeth R Gerstner, Kathryn A Carson, Stuart A Grossman, et al.
Current Opinion in Neurology|November 8, 2008
Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomasElizabeth R Gerstner, A Gregory Sorensen, Rakesh K Jain, et al.
Current Neurology and Neuroscience Reports|April 8, 2009
Anti-vascular endothelial growth factor therapy for malignant gliomaElizabeth R Gerstner, A Gregory Sorensen, Rakesh K Jain, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2023
Labeling T Cells to Track Immune Response to Immunotherapy in GlioblastomaJohn Y Rhee, Jack Y Ghannam, Bryan D Choi, et al.
Cancer Research|September 4, 2014
Advanced magnetic resonance imaging of the physical processes in human glioblastomaJayashree Kalpathy-Cramer, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Journal of Neuro-Oncology|February 26, 2014
Impact of MRI head placement on glioma response assessmentMartin Reuter, Elizabeth R Gerstner, Otto Rapalino, et al.
Current Treatment Options in Oncology|April 22, 2024
Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?Alexander F Wang, Brian Hsueh, Bryan D Choi, et al.
Neuro-Oncology Advances|July 27, 2022
Magnetic resonance spectroscopic imaging for detecting metabolic changes in glioblastoma after anti-angiogenic therapy-a systematic literature reviewMohamed E El-Abtah, Pratik Talati, Jorg Dietrich, et al.
Journal of Neuro-Oncology|February 18, 2009
Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progressionElizabeth R Gerstner, Margaret B McNamara, Andrew D Norden, et al.
Neuro-Oncology Practice|October 13, 2025
A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomasMaya Viera, Christopher W Mount, Dora Dias-Santagata, et al.
Pageof 14